Click on the tab to search across Lilly for additional information
Welcome to Lillyconnect
The Healthcare Professional's connection to Lilly product and condition information

About ZYPREXA® (olanzapine)

About ZYPREXA (olanzapine)

ZYPREXA is the brand name for a medication approved for the short- and long-term treatment of schizophrenia. ZYPREXA is also approved for the treatment of acute mixed or manic episodes of bipolar I disorder alone or in combination with valproate or lithium, and for maintenance treatment in bipolar disorder. Full Prescribing Information
Facts About ZYPREXA:
  • ZYPREXA has been prescribed to nearly 20 million people in 84 countries since its approval in 1996
  • ZYPREXA was the first atypical antipsychotic approved for the treatment of acute bipolar mania
  • ZYPREXA controls positive symptoms (hallucinations, delusions) and negative symptoms (apathy, social withdrawal) of schizophrenia
  • ZYPREXA is easy to use – it can be taken once a day, with or without food
Learn more about why so many doctors prefer ZYPREXA Zydis.